Analytes/procedures in
bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
CAP accredited laboratories that perform testing for the detection of somatic single nucleotide variants, insertions, and deletions in BRAF, EGFR, and KRAS by non-NGS methods are required to enroll in either MTP or the respective single gene programs. This includes laboratories that perform non-NGS-based multiplexed assays, and nonmultiplexed assays (eg, Sanger sequencing). Laboratories that perform NGS-based testing of somatic single nucleotide variants, insertions, and deletions in BRAF, KRAS, EGFR, and/or other genes are required to enroll in NGSST as this proficiency testing program provides challenges with lower VAF as well as challenges in other genes commonly inlcuded in NGS-based panels for the identification of somatic variants in solid tumors.
Program Information
- Three 2.0‑μg gDNA (50ng/‑μL) specimens for laboratories performing molecular testing on multiple targets
- For recommendations and requirements, see flow chart
Shipping Schedule
-
Shipment A: February 12
-
Shipment B: August 19